GlycoNet researchers are studying a group of molecules that could provide insight into treating and monitoring neurodegenerative diseases.
Catégorie : Points saillants de la recherche
New research reveals clues to how antibodies get fine-tuned to fight infection
Scientists discover a cellular mechanism that may yield insights into improving vaccines and better understanding cancer and autoimmune diseases.
New treatment could reduce tissue damage in Duchenne muscular dystrophy patients by as much as 50 per cent
A carbohydrate-derived drug shows promise as a treatment to slow progression of the most common form of muscular dystrophy.
Making strides in Alzheimer’s research
GlycoNet researchers have made exciting advances in understanding Alzheimer’s disease and are developing a potential therapeutic strategy.
Enzymes in bacteria found to have an unexpected taste for carbs
GlycoNet researchers studying complex enzymes gain insight into how some pathogens could potentially be targeted without antibiotics.
SARS-CoV-2 uses sugars to invade human cells, new study shows
Understanding the process could help scientists look out for new, more infectious variants, say GlycoNet researchers.
New anti-diabetic treatment approved for human trials
A natural compound that slows the breakdown of starch could be used to develop a more pleasant treatment for managing Type 2 diabetes.
Innovative coating for blood vessels reduces rejection of transplanted organs
Knowledge in the sugars that coat blood vessels helps researchers find a way to reduce organ rejection.
Solving blood supply shortage with glycomics
GlycoNet Investigators study the sugars on red blood cells to find ways to make universal donor blood
Carbohydrate ‘cage’ allows precise drug delivery to inflammation site in the gastrointestinal tract
A GlycoCage technology developed by GlycoNet researchers aims to improve current treatments for inflammatory bowel disease
French 
English